Zymeworks Inc.
ZYME
$27.50
-$0.62-2.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -69.78% | -12.98% | 38.87% | 116.21% | 95.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -69.78% | -12.98% | 38.87% | 116.21% | 95.94% |
| Cost of Revenue | -10.37% | -2.71% | 0.37% | 14.57% | 18.60% |
| Gross Profit | -341.64% | -18.10% | 48.44% | 86.64% | 64.48% |
| SG&A Expenses | 3.24% | -4.95% | 0.01% | 3.53% | -2.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.27% | -3.40% | 0.26% | 10.98% | 11.52% |
| Operating Income | -88.08% | -4.82% | 23.95% | 42.41% | 32.00% |
| Income Before Tax | -124.53% | 2.99% | 31.61% | 52.50% | 41.86% |
| Income Tax Expenses | -122.36% | -120.15% | -77.38% | 269.10% | 280.20% |
| Earnings from Continuing Operations | -103.59% | 9.70% | 33.88% | 44.20% | 34.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -103.59% | 9.70% | 33.88% | 44.20% | 34.52% |
| EBIT | -88.08% | -4.82% | 23.95% | 42.41% | 32.00% |
| EBITDA | -107.49% | -8.56% | 24.95% | 46.85% | 35.57% |
| EPS Basic | -106.09% | 8.99% | 33.40% | 43.94% | 35.69% |
| Normalized Basic EPS | -127.50% | -15.01% | 20.61% | 45.22% | 34.43% |
| EPS Diluted | -105.92% | 8.96% | 33.23% | 43.73% | 35.74% |
| Normalized Diluted EPS | -127.44% | -15.12% | 20.54% | 45.19% | 34.41% |
| Average Basic Shares Outstanding | -0.84% | -0.41% | -0.59% | 0.46% | 2.48% |
| Average Diluted Shares Outstanding | -1.54% | 0.23% | 0.07% | 1.16% | 3.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |